Targacept's Series A Round

Targacept raised a round of funding on December 19, 2000.

Targacept is a biopharmaceutical company advancing NNR Therapeutics for the treatment of various diseases and disorders. The company's NNR Therapeutics selectively target neuronal nicotinic receptors,…

Articles about Targacept's Series A Round: